These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27577547)

  • 1. Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.
    Kapoor R; Tan-Koi WC; Teo YY
    Eur J Hum Genet; 2016 Dec; 24(12):1651-1657. PubMed ID: 27577547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?
    Johnson JA; Weitzel KW
    Clin Pharmacol Ther; 2016 Feb; 99(2):154-6. PubMed ID: 26440500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Pharmacogenomics: achievements, challenges and prospects, for patients, pharmaceutical industries and healthcare systems".
    Sanoudou D
    Curr Pharm Des; 2010; 16(20):2182-3. PubMed ID: 20459384
    [No Abstract]   [Full Text] [Related]  

  • 4. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 5. On the readiness of physicians for pharmacogenomics testing: an empirical assessment.
    Amara N; Blouin-Bougie J; Bouthillier D; Simard J
    Pharmacogenomics J; 2018 Apr; 18(2):308-318. PubMed ID: 28607504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bring on the biomarkers.
    Poste G
    Nature; 2011 Jan; 469(7329):156-7. PubMed ID: 21228852
    [No Abstract]   [Full Text] [Related]  

  • 7. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
    Johnson JA; Burkley BM; Langaee TY; Clare-Salzler MJ; Klein TE; Altman RB
    Clin Pharmacol Ther; 2012 Oct; 92(4):437-9. PubMed ID: 22910441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARC report: health outcomes and value of personalized medicine interventions: impact on patient care.
    Mitropoulou C; Litinski V; Kabakchiev B; Rogers S; P Patrinos G
    Pharmacogenomics; 2020 Jul; 21(11):797-807. PubMed ID: 32635813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
    Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
    OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics: questions and concerns.
    Mahlknecht U; Voelter-Mahlknecht S
    Curr Med Res Opin; 2005 Jul; 21(7):1041-7. PubMed ID: 16004671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inaugural Pharmacogenomics Access and Reimbursement Symposium.
    Rogers SL; Patrinos GP; Mitropoulou C; Formea CM; Jones JS; Brown BG
    Pharmacogenomics; 2021 Jun; 22(9):515-517. PubMed ID: 34032472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalizing medicine with clinical pharmacogenetics.
    Scott SA
    Genet Med; 2011 Dec; 13(12):987-95. PubMed ID: 22095251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics.
    Johnson JA; Elsey AR; Clare-Salzler MJ; Nessl D; Conlon M; Nelson DR
    Pharmacogenomics; 2013 May; 14(7):723-6. PubMed ID: 23651020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and cost-effectiveness analysis: a two-way street.
    Chalkidou K; Rawlins M
    Drug Discov Today; 2011 Oct; 16(19-20):873-7. PubMed ID: 21903176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scanning the human genome and the horizon: the potential and pitfalls of pharmacogenetics and stratified medicine.
    Jennings BA; Shakespeare T; Loke YK
    Br J Gen Pract; 2015 Jun; 65(635):284-5. PubMed ID: 26009508
    [No Abstract]   [Full Text] [Related]  

  • 17. Stratified medicine: making it happen.
    Foot E
    Drug Discov Today; 2011 Oct; 16(19-20):848-9. PubMed ID: 21920455
    [No Abstract]   [Full Text] [Related]  

  • 18. Update: healthcare reform - it's getting personal.
    Shapiro SD
    Per Med; 2017 Jul; 14(4):281-283. PubMed ID: 29749829
    [No Abstract]   [Full Text] [Related]  

  • 19. Tabula Rasa HealthCare company profile: involvement in pharmacogenomic and personalized medicine research.
    Matos A; Dow P; Bingham JM; Michaud V; Lesko LJ; Knowlton CH; Turgeon J
    Pharmacogenomics; 2021 Aug; 22(12):731-735. PubMed ID: 34284600
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics: Chasing Perfection.
    Gaedigk A
    Clin Pharmacol Ther; 2019 Aug; 106(2):265-270. PubMed ID: 31355458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.